We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Expression of Cyclin D1 and Its Relationship to Hormone Receptors and Survival in Breast Cancer.
- Authors
ALANYALI, Senem; YENIAY, Levent; DEMIR, Derya; AYDIN, Barbaros; ZEKIOĞLU, Osman; ÖZDEMIR, Necmettin; KITAPÇIOĞLU, Gül; HAYDAROĞLU, Ayfer
- Abstract
OBJECTIVE The aim of the present study was to evaluate rate of cyclin D1 expression and examine its relationship to clinicopathological factors and impact on prognosis in breast cancer patients. METHODS Total of 85 estrogen receptor (ER)-positive breast cancer patients were included. Expression of cyclin D1, ER, progesterone receptor (PR), and Ki-67 were determined using immunohistochemistry evaluation. RESULTS Patients' median age was 49 years (range: 27-83 years) and cyclin D1 was positive in 90.5% of the patients. Cyclin D1 expression was positively correlated with rate of ER positivity and Ki-67 expression (r=0.4; p<0.0001 and r=0.3; p=0.001, respectively). Five-year disease-free and overall survival (OS) rates were not different between patients with or without cyclin D1 expression (81% vs 79% and 93% vs 87%; p=0.8 and 0.4, respectively). High modified Bloom-Richardson grade (p=0.04), high nuclear grade (p=0.021), and PR negativity (p=0.011) were found to be poor prognostic factors for OS rate in univariate analysis. CONCLUSION In this study, cyclin D1 was not found to be prognostic factor; however, it is correlated with ER positivity and Ki-67 expression in breast cancer patients.
- Publication
Turkish Journal of Oncology / Türk Onkoloji Dergisi, 2017, Vol 32, Issue 1, p7
- ISSN
1300-7467
- Publication type
Article
- DOI
10.5505/tjo.2017.1523